Synthesis and cyclic voltammetry studies of 3,4- methylenedioxymethamphetamine (MDMA) human metabolites

Journal of Health Science

Volumn 53, Issue 1, 2007, Pages 31-42

  Macedo, Carla ^a   Branco, Paula Sério ^a   Ferreira, Luísa Maria ^a   Lobo, Ana Maria ^a   Capela, João Paulo ^b   Fernandes, Eduarda ^b   Bastos, Maria De Lourdes ^b   Carvalho, Felix ^b  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b Faculdade de Farmácia da Universidade do Porto   (Portugal)

Author keywords

3,4 Methylenedioxymethamphetamine; Cyclic voltammetry; Metabolites; Neurotoxicity; Rat cortical neurons

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 (GLUTATHION YL)ALPHA METHYLDOPAMINE; ALPHA METHYLDOPAMINE; CARBON; N METHYL ALPHA METHYLDOPAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN CELL; CYCLIC POTENTIOMETRY; ELECTROCHEMISTRY; ELECTRODE; METABOLITE; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; PREDICTION; RAT; SYNTHESIS;

MEDA; RATTUS;

EID: 33846877453     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.53.31     Document Type: Article

References (46)

1. Kenny, P. J. and Markou, A. (2004) The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol. Sci., 25, 265-272.
2. Commins, D. L., Vosmer, G., Virus, R. M., Woolverton, W. L., Schuster, C. R. and Seiden, L. S. (1987) Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat-brain. J. Pharmacol. Exp. Ther., 241, 338-346.
3. Ricaurte, G., Bryan, G., Strauss, L., Seiden, L. and Schuster, C. (1985) Hallucinogenic amphetamine selectively destroys brain-serotonin nerve-terminals. Science, 229, 986-988.
4. Green, A. R., Mechan, A. O., Elliot, J. M., O'Shea, E. and Colado, M. I. (2003) The Pharmacology and Clinical Pharmacology of 3,4- Methylenedioxymethamphetamine (MDMA, "Ecstasy"). Pharmacol. Rev., 55, 463-508.
5. Esteban, B., O'Shea, E., Camarero, J., Sanchez, V., Green, A. R. and Colado, M. I. (2001) 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected nenrotoxic dose. Psychopharmacology, 154, 251-260.
6. Monks, T. J., Jones, D. C., Bai, F. J. and Lau, S. S. (2004) The role of metabolism in 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)- methylenedioxymethamphetamine (ecstasy) toxicity. Ther. Drug Monit., 26, 132-136.
7. Schmidt, C. J. and Taylor,V. L. (1988) Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons. Eur. J. Pharmacol., 156, 121-131.
8. Kumagai, Y., Lin, L. Y., Hiratsuka, A., Narimatsu, S., Suzuki, T., Yamada, H., Oguri, K., Yoshimura, H. and Cho, A. K. (1994) Participation Of Cytochrome P450-2b And P450-2d Isozymes In The Demethylenation Of Methylenedioxymethamphetamine Enantiomers By Rats. Mol. Pharmacol., 45, 359-365.
9. Lim, H. K. and Foltz, R. L. (1988) Invivo and invitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat - identification of metabolites using an ion trap detector. Chem. Res. Toxicol., 1, 370-378.
10. Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G. and Monks, T. J. (2000) Role of quinones in toxicology. Chem. Res. Toxicol., 13, 135-160.
11. 2+-induced isoproterenol oxidation into isoprenochrome in adult rat calcium-tolerant cardiomyocytes. Chem. Res. Toxicol., 15, 861-869.
12. Kovacic, P. (2005) Unifying mechanism for addiction and toxicity of abused drugs with application to dopamine and glutamate mediators: Electron transfer and reactive oxygen species. Med. Hypotheses, 65, 90-96.
13. Kovacic, P. and Cooksy, A. L. (2005) Unifying mechanism for toxicity and addiction by abused drugs: electron transfer and reactive oxygen species. Med. Hypotheses, 64, 357-366.
14. Hawley, M. D., Tatawawa, S. V., Piekarsk, S. and Adams, R. N. (1967) Electrochemical studies of oxidation pathways of catecholamines. J. Am. Chem. Soc., 89, 447-450.
15. Li, Y. L., Liu, M. L., Xiang, C. H., Xie, Q. J. and Yao, S. Z. (2006) Electrochemical quartz crystal microbalance study on growth and property of the polymer deposit at gold electrodes during oxidation of dopamine in aqueous solutions. Thin Solid Films, 497, 270-278.
16. Miller, R. T., Lau, S. S. and Monks, T. J. (1997) 2,5-Bis-(glutathion-S- yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4- methylenedioxyamphetamine, decreases brain serotonin concentrations. Eur. J. Pharmacol., 323, 173-180.
17. Capela, J. P., Meisel, A., Abreu, A. R., Branco, P. S., Ferreira, L. M., Lobo, A. M., Remiao, F., Bastos, M. L. and Carvalho, F. (2006) Neurotoxicity of ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. J. Pharmacol. Exp. Ther., 316, 53-61.
18. Carvalho, M., Hawksworth, G., Milhazes, N., Borges, F., Monks, T., Fernandes, E., Carvalho, F. and Bastos, M. D. L. (2002) Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using Rat and Human renal proximal tubular cells. Arch. Toxicol., 76, 581-588.
19. Carvalho, M., Remião, F., Milhazes, N., Borges, F., Fernandes, E., Carvalho, F. and Bastos, M. L. (2004) The toxicity of N-methyl-α- methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine. Toxicology, 200, 193-203.
20. Carvalho, M., Remiao, F., Milhazes, N., Borges, F., Fernandes, E., Monteiro, M. D., Goncalves, M. J., Seabra, V., Amado, F., Carvalho, F. and Bastos, M. L. (2004) Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro. Chem. Res. Toxicol., 17, 623-632.
21. Armarego, W. L. F. and Perrin, D. D. (1996) Purification of Laboratory Chemicals, Oxford, Butterworth-Heinemann.
22. Borgman, R. J., Baylor, M. R., McPhilli.Jj and Stitzel, R. E. (1974) α-Methyldopamine Derivative - Synthesis and Pharmacology. J. Med. Chem., 17, 427-430.
23. Pizarro, N., de la Torre, R., Farre, M., Segura, J., Llebaria, A. and Joglar, J. (2002) Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites. Bioorg. Med. Chem., 10, 1085-1092.
24. Shulgin, A. T. (1964) Psychotomimetic amphetamines: methoxy 3,4-dialkoxyamphetamines. Experientia, 20, 366-367.
25. Ho, B. T., McIsaac, W. M., An, R., Tansey, L. W., Walker, K. E., Englert, L. F. and Noel, M. B. (1970) Analogs of α-methylphenethlamine (amphetamine). 1. Synthesis and pharmacological activity of some methoxy and/or methyl analogs. J. Med. Chem., 13, 26-30.
26. Hiramatsu, M., Kumagai, Y., Unger, S. E. and Cho, A. K. (1990) Metabolism of methylenedioxymethamphetamine - formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J. Pharmacol. Exp. Ther., 254, 521-527.
27. Miller, R. T., Lau, S. S. and Monks, T. J. (1995) Metabolism of 5-(glutathione-S-yl)-α-methyldopamine following intracerebroventricular administration to male Sprague-Dawley rats. Chem. Res. Toxicol., 8, 634-641.
28. Jones, D. C., Duvauchelle, C., Ikegami, A., Olsen, C. M., Lau, S. S., de la Torre, R. and Monks, T. J. (2005) Serotonergic neurotoxic metabolites of ecstasy identified in rat brain. J. Pharmacol. Exp. Ther., 313, 422-431.
29. Shen, X. M. and Dryhurst, G. (1996) Influence of L-cysteine on the oxidation chemistry of (-)-epinephrine: Formation of cysteinyl conjugates and novel dihydrobenzothiazines. Bioorg. Chem., 24, 340-357.
30. Ball, E. G. and Chen, T.-T. (1933) Studies on oxidation-reduction. XX. Epinephine and related compounds. J. Biol. Chem., 102, 691-719.
31. Paris, J. M. and Cunningham, K. A. (1992) Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA). Brain Res. Bull., 28, 115-119.
32. Capela, J. P., Ruscher, K., Lautenschlager, M., Freyer, D., Dirnagl, U., Bastos, M. L., Meisel, A. and Carvalho, F. (2006) Ecstasy-induced cell death in cortical neuronal cultures is 5HT2A-receptor-dependent and potentiated under hyperthermia. Neuroscience, 139, 1069-1081.
33. Monks, T. J. and Lau, S. S. (1997) Biological reactivity of polyphenolic-glutathione conjugates. Chem. Res. Toxicol., 10, 1296-1313.
34. Monks, T. J. and Lau, S. S. (1998) The pharmacology and toxicology of polyphenolic-glutathione conjugates. Annu. Rev. Pharmacol. Toxicol., 38, 229-255.
35. Patel, N., Kumagai, Y., Unger, S. E., Fukuto, J. M. and Cho, A. K. (1991) Transformation of dopamine and α-methyldopamine by Ng108-15-cells - formation of thiol adducts. Chem. Res. Toxicol., 4, 421-426.
36. Kiani, A., Raoof, J. B., Nematollahi, D. and Ojani, R. (2005) Electrochemical study of catechol in the presence of dibuthylamine and diethylamine in aqueous media: Part 1. Electrochemical investigation. Electroanalysis, 17, 1755-1760.
37. Nematollahi, D., Tammari, E., Sharifi, S. and Kazemi, M. (2004) Mechanistic study of the oxidation of catechol in the presence of secondary amines by digital simulation of cyclic voltammograms. Electrochim. Acta, 49, 591-595.
38. Shahrokhian, S. and Amiri, M. (2005) Mercaptotriazole as a nucleophile in addition to o-quinone electrochemically derived from catechol: application to electrosynthesis of a new group of triazole compounds. Electrochem. Commun., 7, 68-73.
39. Cui, H., Wu, L. S., Chen, J. and Lin, X. Q. (2001) Multi-mode in situ spectroelectrochemical studies of redox pathways of adrenaline. J. Electroanal. Chem., 504, 195-200.
40. Shen, X. M. and Dryhurst, G. (1997) Further insights into the oxidation chemistry of norepinephrine and epinephrine in the presence of cysteine. Bioorg. Chem., 25, 130-153.
41. Solomons, T. W. G. and Fryhle, C. B. (2004) Organic Chemistry, Wiley.
42. Fang, Y., Liu, L., Feng, Y., Li, X. S. and Guo, Q. X. (2002) Effects of hydrogen bonding to amines on the phenol/phenoxyl radical oxidation. J. Phys. Chem. A, 106, 4669-4678.
43. Lal, M., Langels, A., Deiseroth, H. J., Schlirf, J. and Schmittel, M. (2003) Role of hydrogen bonding in the oxidation potential of enols. J. Phys. Org. Chem., 16, 373-379.
44. Erve, J. C. L., Svensson, M. A., von Euler-Chelpin, H. and Klasson-Wehler, E. (2004) Characterization of glutathione conjugates of the remoxipride hydroquinone metabolite NCQ-344 formed in vitro and detection following oxidation by human neutrophils. Chem. Res. Toxicol., 17, 564-571.
45. Bai, F. J., S. S. Lau and Monks, T. J. (1999) G;itathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: Possible role in methylenedioxyamphetamine-mediated neurotoxicity. Chem. Res. Toxicol., 12, 1150-1157.
46. Miller, R. T., S. S. Lau and Monks, T. J. (1997) 2,5-Bis-(glutathion-S- yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4- methylenedioxyamphetamine, decreases brain serotonin concentrations. Eur. J. Pharmacol., 323, 173-180.